Validation of the 70-gene signature test (MammaPrint) to identify patients with breast cancer aged ≥70 years with ultralow risk of distant recurrence: A population-based cohort study

被引:2
|
作者
Mansani, Fabio P. [1 ]
Freitas-Junior, Ruffo [2 ]
机构
[1] Univ Estadual Ponta Grossa, Ponta Grossa, PR, Brazil
[2] Univ Fed Goias, Goiania, Brazil
关键词
Breast cancer; Endocrine therapy; Geriatric oncology; Genomic risk profile; Individualized treatment;
D O I
10.1016/j.jgo.2023.101526
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
[No abstract available]
引用
收藏
页数:2
相关论文
共 50 条
  • [21] 20-year benefit of endocrine therapy in premenopausal breast cancer patients by the 70-gene risk signature
    Johansson, A.
    Dar, H.
    Van'T Veer, L.
    Perez-Tenorio, G.
    Nordenskjold, A.
    Yau, C.
    Benz, C.
    Esserman, L.
    Stal, O.
    Nordenskjold, B.
    Fornander, T.
    Lindstrom, L.
    ANNALS OF ONCOLOGY, 2021, 32 : S21 - S21
  • [22] Adjuvant chemotherapy and survival in males aged 70 years or older with breast cancer: a population-based retrospective study
    Yushuai Yu
    Kaiyan Huang
    Yushan Liu
    Ruiliang Chen
    Xin Yu
    Chuangui Song
    BMC Geriatrics, 24
  • [23] Adjuvant chemotherapy and survival in males aged 70 years or older with breast cancer: a population-based retrospective study
    Yu, Yushuai
    Huang, Kaiyan
    Liu, Yushan
    Chen, Ruiliang
    Yu, Xin
    Song, Chuangui
    BMC GERIATRICS, 2024, 24 (01)
  • [24] Utility of the 70-gene MammaPrint test for prediction of extended endocrine therapy benefit in patients with early-stage breast cancer in the IDEAL Trial
    Liefers, Gerrit-Jan
    Kranenbarg, Elma Meershoek-Klein
    Duijm-de Carpentier, Marjolijn
    van de Velde, Cornelis J. H.
    Kleijn, Miranda
    Dreezen, Christa
    Menicucci, Andrea
    Van't Veer, Laura
    Audeh, William
    CANCER RESEARCH, 2023, 83 (05)
  • [25] Nomogram prediction of the 70-gene signature (MammaPrint) binary and quartile categorized risk using medical history, imaging features and clinicopathological data among Chinese breast cancer patients
    Pan, Bo
    Xu, Ying
    Yao, Ru
    Cao, Xi
    Zhou, Xingtong
    Hao, Zhixin
    Zhang, Yanna
    Wang, Changjun
    Shen, Songjie
    Luo, Yanwen
    Zhu, Qingli
    Ren, Xinyu
    Kong, Lingyan
    Zhou, Yidong
    Sun, Qiang
    JOURNAL OF TRANSLATIONAL MEDICINE, 2023, 21 (01)
  • [26] Nomogram prediction of the 70-gene signature (MammaPrint) binary and quartile categorized risk using medical history, imaging features and clinicopathological data among Chinese breast cancer patients
    Bo Pan
    Ying Xu
    Ru Yao
    Xi Cao
    Xingtong Zhou
    Zhixin Hao
    Yanna Zhang
    Changjun Wang
    Songjie Shen
    Yanwen Luo
    Qingli Zhu
    Xinyu Ren
    Lingyan Kong
    Yidong Zhou
    Qiang Sun
    Journal of Translational Medicine, 21
  • [27] MINDACT: Long-term results of the large prospective trial testing the 70-gene signature MammaPrint as guidance for adjuvant chemotherapy in breast cancer patients.
    Cardoso, Fatima
    van't Veer, Laura
    Poncet, Coralie
    Cardozo, Josephine Lopes
    Delaloge, Suzette
    Pierga, Jean-Yves
    Vuylsteke, Peter
    Brain, Etienne
    Viale, Giuseppe
    Kuemmel, Sherko
    Rubio, Isabel T.
    Zoppoli, Gabriele
    Thompson, Alastair Mark
    Matos, Erika
    Zaman, Khalil
    Hilbers, Florentine
    Dudek-Peric, Aleksandra
    Meulemans, Bart
    Piccart-Gebhart, Martine J.
    Rutgers, Emiel J.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [28] Incidence and risk factors of cardiovascular disease among population aged 40–70 years: a population-based cohort study in the South of Iran
    Abbas Rezaianzadeh
    Leila Moftakhar
    Mozhgan Seif
    Masoumeh Ghoddusi Johari
    Seyed Vahid Hosseini
    Seyed Sina Dehghani
    Tropical Medicine and Health, 51
  • [29] An association study of established breast cancer reproductive and lifestyle risk factors with tumour subtype defined by the prognostic 70-gene expression signature (MammaPrint®) (vol 75, pg 5, 2017)
    Makama, M.
    Drukker, C. A.
    Rutgers, E. J. Th.
    Slaets, L.
    Cardoso, F.
    Rookus, M. A.
    Tryfonidis, K.
    Van't Veer, L. J.
    Schmidt, M. K.
    EUROPEAN JOURNAL OF CANCER, 2018, 96 : 131 - 132
  • [30] The 70-gene prognosis-signature predicts disease outcome in breast cancer patients with 1–3 positive lymph nodes in an independent validation study
    Stella Mook
    Marjanka K. Schmidt
    Giuseppe Viale
    Giancarlo Pruneri
    Inge Eekhout
    Arno Floore
    Annuska M. Glas
    Jan Bogaerts
    Fatima Cardoso
    Martine J. Piccart-Gebhart
    Emiel T. Rutgers
    Laura J. van’t Veer
    Breast Cancer Research and Treatment, 2009, 116 : 295 - 302